• 1
    Berger L, Luc G, Richard D. L'esthésioneuroépithéliome olfactif. Bull Assoc Franç Étude Cancer 1924; 13:410421.
  • 2
    Broich G, Pagliari A and Ottaviani F. Esthesioneuroblastoma: a general review of the cases published since the discovery of the tumour in 1924. Anticancer Research 1997; 17: 26832706.
  • 3
    Theilgaard SA, Buchwald C, Ingeholm P, Kornum Larsen S, Eriksen JG and Sand Hansen H. Esthesioneuroblastoma: a Danish demographic study of 40 patients registered between 1978 and 2000. Acta Oto-Laryngologica 2003; 123: 433439.
  • 4
    Servenius B, Vernachio J, Price J, Andersson LC and Peterson PA. Metastasizing neuroblastomas in mice transgenic for simian virus 40 large T (SV40T) under the olfactory marker protein gene promoter. Cancer Research 1994; 54: 51985205.
  • 5
    Delattre O, Zucman J, Melot T, Garau XS, Zucker JM, Lenoir GM, Ambros PF, Sheer D, Turc-Carel C, Triche TJ, Aurias A, Thomas G. The Ewing family of tumors–a subgroup of small-round-cell tumors defined by specific chimeric transcripts. The New England Journal of Medicine 1994; 331: 294299.
  • 6
    Sorensen PH, Wu JK, Berean KW, Lim JF, Donn W, Frierson HF, Reynolds CP, Lopez-Terrada D and Triche TJ. Olfactory neuroblastoma is a peripheral primitive neuroectodermal tumor related to Ewing sarcoma. Proceedings of the National Academy of Sciences of the United States of America 1996; 93: 10381043.
  • 7
    Nelson RS, Perlman EJ and Askin FB. Is esthesioneuroblastoma a peripheral neuroectodermal tumor? Human Pathology 1995; 26: 639641.
  • 8
    Kumar S, Perlman E, Pack S, Davis M, Zhang H, Meltzer P and Tsokos M. Absence of EWS/FLI1 fusion in olfactory neuroblastomas indicates these tumors do not belong to the Ewing's sarcoma family. Human Pathology 1999; 30: 13561360.
  • 9
    Mezzelani A, Tornielli S, Minoletti F, Pierotti MA, Sozzi G and Pilotti S. Esthesioneuroblastoma is not a member of the primitive peripheral neuroectodermal tumour-Ewing's group. British Journal of Cancer 1999; 81: 586591.
  • 10
    Pellin A, Boix J, Blesa JR, Noguera R, Carda C and Llombart-Bosch A. EWS/FLI-1 rearrangement in small round cell sarcomas of bone and soft tissue detected by reverse transcriptase polymerase chain reaction amplification. European Journal of Cancer 1994; 30A: 827831.
  • 11
    Brosinski K, Janik D, Polkinghorne A, Von Bomhard W and Schmahl W. Olfactory neuroblastoma in dogs and cats–a histological and immunohistochemical analysis. Journal of Comparative Pathology 2012; 146: 152159.
  • 12
    Ueno H, Kobayashi Y and Yamada K. Olfactory esthesioneuroblastoma treated with orthovoltage radiotherapy in a dog. Australian Veterinary Journal 2007; 85: 271275.
  • 13
    Parker VJ, Morrison JA and Yaeger MJ. Olfactory neuroblastoma in a cat. Journal of Feline Medicine and Surgery 2010; 12: 867871.
  • 14
    Anderson BC and Cordy DR. Olfactory neuroblastoma in a heifer. Veterinary Pathology 1981; 18: 536540.
  • 15
    Dopke C, Grone A, von Borstel M, von Oppen T, Boeve MH and Baumgartner W. Metastatic esthesioneuroblastoma in a horse. Journal of Comparative Pathology 2005; 132: 218222.
  • 16
    Yamate J, Izawa T, Ogata K, Kobayashi O, Okajima R, Kuwamura M, Kotani T and Aoki M. Olfactory neuroblastoma in a horse. The Journal of Veterinary Medical Science 2006; 68: 495498.
  • 17
    Vigliano FA, Marcaccini AJ, Sarradell J, Bermudez R and Quiroga MI. First description of an olfactory neuroblastoma in goldfish Carassius auratus: a case report. Diseases of Aquatic Organisms 2011; 96: 6168.
  • 18
    Torikata C, Mukai M and Kageyama K. Spontaneous olfactory neuroepithelioma in a domestic medaka (Oryzias latipes). Cancer Research 1989; 49: 29942998.
  • 19
    Shioda C, Uchida K and Nakayama H. Pathological features of olfactory neuroblastoma in an axolotl (Ambystoma mexicanum). The Journal of Veterinary Medical Science 2011; 73: 11091111.
  • 20
    Koike K, Jay G, Hartley JW, Schrenzel MD, Higgins RJ and Hinrichs SH. Activation of retrovirus in transgenic mice: association with development of olfactory neuroblastoma. Journal of Virology 1990; 64: 39883991.
  • 21
    Thompson LD. Olfactory neuroblastoma. Head and Neck Pathology 2009; 3: 252259.
  • 22
    Kadish S, Goodman M and Wang CC. Olfactory neuroblastoma. A clinical analysis of 17 cases. Cancer 1976; 37: 15711576.
  • 23
    Levine PA, Gallagher R and Cantrell RW. Esthesioneuroblastoma: reflections of a 21-year experience. Laryngoscope 1999; 109: 15391543.
  • 24
    Thompson L. Olfactory neuroblastoma. Ear, Nose, & Throat Journal 2006; 85: 569570.
  • 25
    Herrold KM. Induction of olfactory neuroepithelial tumors in Syrian hamsters by diethylnitrosamine. Cancer 1964; 17: 114121.
  • 26
    Vollrath M and Altmannsberger M. Chemically induced esthesioneuroepithelioma: ultrastructural findings. The Annals of Otology, Rhinology, and Laryngology 1989; 98: 256266.
  • 27
    Schrenzel MD, Higgins RJ, Hinrichs SH, Smith MO and Torten M. Type C retroviral expression in spontaneous feline olfactory neuroblastomas. Acta Neuropathologica 1990; 80: 547553.
  • 28
    Dulguerov P and Calcaterra T. Esthesioneuroblastoma: the UCLA experience 1970-1990. Laryngoscope 1992; 102: 843849.
  • 29
    Argiris A, Dutra J, Tseke P and Haines K. Esthesioneuroblastoma: the Northwestern University experience. Laryngoscope 2003; 113: 155160.
  • 30
    Constantinidis J, Steinhart H, Koch M, Buchfelder M, Schaenzer A, Weidenbecher M and Iro H. Olfactory neuroblastoma: the University of Erlangen-Nuremberg experience 1975-2000. Otolaryngology and Head and Neck Surgery 2004; 130: 567574.
  • 31
    Lund VJ, Howard D, Wei W and Spittle M. Olfactory neuroblastoma: past, present, and future? Laryngoscope 2003; 113: 502507.
  • 32
    Axe S and Kuhajda FP. Esthesioneuroblastoma. Intermediate filaments, neuroendocrine, and tissue-specific antigens. American Journal of Clinical Pathology 1987; 88: 139145.
  • 33
    Frierson HF Jr, Ross GW, Mills SE and Frankfurter A. Olfactory neuroblastoma. Additional immunohistochemical characterization. American Journal of Clinical Pathology 1990; 94: 547553.
  • 34
    Lund VJ and Milroy C. Olfactory neuroblastoma: clinical and pathological aspects. Rhinology 1993; 31: 16.
  • 35
    Hirose T, Scheithauer BW, Lopes MB, Gerber HA, Altermatt HJ, Harner SG and VandenBerg SR. Olfactory neuroblastoma. An immunohistochemical, ultrastructural, and flow cytometric study. Cancer 1995; 76: 419.
  • 36
    Ishikawa T, Masahito P and Takayama S. Olfactory neuroepithelioma in a domestic carp (Cyprinus carpio). Cancer Research 1978; 38: 39543959.
  • 37
    Hara K, Shimada A, Morita T, Sawada M and Umemura T. Olfactory neuroepithelioma in a dog: an immunohistochemical and electron microscopic study. The Journal of Veterinary Medical Science 2002; 64: 391393.
  • 38
    Mazzamuto G and Bosschaert P. Unusual initial development of an esthesioneuroblastoma above the cribriform plate. Journal Belge De Radiologie-Belgisch Tijdschrift Voor Radiologie 2012; 95: 8991.
  • 39
    Mariani L, Schaller B, Weis J, Ozdoba C and Seiler RW. Esthesioneuroblastoma of the pituitary gland: a clinicopathological entity? Case report and review of the literature. Journal of Neurosurgery 2004; 101: 10491052.
  • 40
    Lee JY and Kim HK. Primary olfactory neuroblastoma originating from the inferior meatus of the nasal cavity. American Journal of Otolaryngology 2007; 28: 196200.
  • 41
    Kodama S, Kawano T and Suzuki M. Endoscopic transnasal resection of ectopic esthesioneuroblastoma in the pterygopalatine fossa: technical case report. Neurosurgery 2009; 65: E112E113.
  • 42
    Morris L, Govindaraj S and Genden EM. Primary sphenoid sinus esthesioneuroblastoma. American Journal of Otolaryngology 2004; 25: 350353.
  • 43
    Lopez R, Mazzoni L, Chaput B and Jalbert F. Olfactory neuroblastoma presenting with exclusive orbital manifestations. The Journal of Craniofacial Surgery 2013; 24: 667669.
  • 44
    Mhawech P, Berczy M, Assaly M, Herrmann F, Bouzourene H, Allal AS, Dulguerov P and Schwaller J. Human achaete-scute homologue (hASH1) mRNA level as a diagnostic marker to distinguish esthesioneuroblastoma from poorly differentiated tumors arising in the sinonasal tract. American Journal of Clinical Pathology 2004; 122: 100105.
  • 45
    Bridge JA, Bowen JM and Smith RB. The small round blue cell tumors of the sinonasal area. Head and Neck Pathology 2010; 4: 8493.
  • 46
    Bellizzi AM, Bourne TD, Mills SE and Stelow EB. The cytologic features of sinonasal undifferentiated carcinoma and olfactory neuroblastoma. American Journal of Clinical Pathology 2008; 129: 367376.
  • 47
    Han A, Kristjansson AK, Gilliam AC, Jacobs G and Eisenberg R. Pigmented olfactory neuroblastoma: a CD56-positive mimic of melanoma. Archives of Dermatology 2008; 144: 270272.
  • 48
    Wooff JC, Weinreb I, Perez-Ordonez B, Magee JF and Bullock MJ. Calretinin staining facilitates differentiation of olfactory neuroblastoma from other small round blue cell tumors in the sinonasal tract. The American Journal of Surgical Pathology 2011; 35: 17861793.
  • 49
    Matayoshi R and Otaki JM. Immunohistochemical detection of olfactory-specific sensory transduction proteins in olfactory neuroblastoma. Neuroscience Research 2011; 69: 258262.
  • 50
    Thomas L. Sur un cas de stiboneuroépithélioblastome chez une Daurade. Bulletin de l'Association francaise pour l'étude du cancer, Paris. 1932; 21: 385396.
  • 51
    Dawe CJ and Harshbarger JC. Neoplasms in feral fishes: their significance to cancer research. In: The Pathology of Fishes. WE Ribelin and G Migaki Eds., Madison, University of Wisconsin Press, 1975: 871894.
  • 52
    Bak M and Wein RO. Esthesioneuroblastoma: a contemporary review of diagnosis and management. Hematology/Oncology Clinics of North America 2012; 26: 11851207.
  • 53
    Kane AJ, Sughrue ME, Rutkowski MJ, Aranda D, Mills SA, Buencamino R, Fang S, Barani IJ and Parsa AT. Posttreatment prognosis of patients with esthesioneuroblastoma. Journal of Neurosurgery 2010; 113: 340351.
  • 54
    Preusser M, Hutterer M, Sohm M, Koperek O, Elandt K, Dieckmann K, Prayer D and Marosi C. Disease stabilization of progressive olfactory neuroblastoma (esthesioneuroblastoma) under treatment with sunitinib mesylate. Journal of Neuro-Oncology 2010; 97: 305308.
  • 55
    Dunbar EM, Pumphrey PK and Bidari S. Unexpectedly durable palliation of metastatic olfactory neuroblastoma using anti-angiogenic therapy with Bevacizumab. Rare Tumors 2012; 4: e33.
  • 56
    Wick W, Wick A, Kuker W, Dichgans J and Weller M. Intracranial metastatic esthesioneuroblastoma responsive to temozolomide. Journal of Neuro-Oncology 2004; 70: 7375.
  • 57
    Mao L, Xia YP, Zhou YN, Dai RL, Yang X, Wang YJ, Duan SJ, Qiao X, Mei YW and Hu B. Activation of sonic hedgehog signaling pathway in olfactory neuroblastoma. Oncology 2009; 77: 231243.
  • 58
    Koschny R, Holland H, Sykora J, Erdal H, Krupp W, Bauer M, Bockmuehl U, Ahnert P, Meixensberger J, Stremmel W, Walczak H and Ganten TM. Bortezomib sensitizes primary human esthesioneuroblastoma cells to TRAIL-induced apoptosis. Journal of Neuro-Oncology 2010; 97: 171185.
  • 59
    Kim JW, Kong IG, Lee CH, Kim DY, Rhee CS, Min YG, Kim CW and Chung JH. Expression of Bcl-2 in olfactory neuroblastoma and its association with chemotherapy and survival. Otolaryngology and Head and Neck Surgery 2008; 139: 708712.
  • 60
    Fukushima S, Sugita Y, Niino D, Mihashi H and Ohshima K. Clincopathological analysis of olfactory neuroblastoma. Brain Tumor Pathology 2012; 29: 207215.
  • 61
    Diensthuber M, Potinius M, Rodt T, Stan AC, Welkoborsky HJ, Samii M, Schreyogg J, Lenarz T and Stover T. Expression of bcl-2 is associated with microvessel density in olfactory neuroblastoma. Journal of Neuro-Oncology 2008; 89: 131139.
  • 62
    Weiss GJ, Liang WS, Izatt T, Arora S, Cherni I, Raju RN, Hostetter G, Kurdoglu A, Christoforides A, Sinari S, Baker AS, Metpally R, Tembe WD, Phillips L, Von Hoff DD, Craig DW and Carpten JD. Paired tumor and normal whole genome sequencing of metastatic olfactory neuroblastoma. PloS One 2012; 7: e37029.